Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Effect of serial infusions of reconstituted high-density lipoprotein (CER-001) on coronary atherosclerosis: rationale and design of the CARAT study.

Andrews J, Janssan A, Nguyen T, Pisaniello AD, Scherer DJ, Kastelein JJ, Merkely B, Nissen SE, Ray K, Schwartz GG, Worthley SG, Keyserling C, Dasseux JL, Butters J, Girardi J, Miller R, Nicholls SJ.

Cardiovasc Diagn Ther. 2017 Feb;7(1):45-51. doi: 10.21037/cdt.2017.01.01.

2.

Endothelial progenitor cells: Exploring the pleiotropic effects of statins.

Sandhu K, Mamas M, Butler R.

World J Cardiol. 2017 Jan 26;9(1):1-13. doi: 10.4330/wjc.v9.i1.1. Review.

3.
4.

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques.

Horvath M, Hajek P, Stechovsky C, Honek J, Spacek M, Veselka J.

Arch Med Sci. 2016 Dec 1;12(6):1308-1316.

5.

Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date.

McCormack T, Dent R, Blagden M.

Int J Clin Pract. 2016 Nov;70(11):886-897. doi: 10.1111/ijcp.12881. Review.

6.

Coronary CT Angiography: Variability of CT Scanners and Readers in Measurement of Plaque Volume.

Symons R, Morris JZ, Wu CO, Pourmorteza A, Ahlman MA, Lima JA, Chen MY, Mallek M, Sandfort V, Bluemke DA.

Radiology. 2016 Dec;281(3):737-748.

PMID:
27636027
7.

Prevalence and Factors Associated With Statin Use Among a Nationally Representative Sample of US Adults: National Health and Nutrition Examination Survey, 2011-2012.

Adedinsewo D, Taka N, Agasthi P, Sachdeva R, Rust G, Onwuanyi A.

Clin Cardiol. 2016 Sep;39(9):491-6. doi: 10.1002/clc.22577.

8.

Characterization of coronary atherosclerosis by intravascular imaging modalities.

Honda S, Kataoka Y, Kanaya T, Noguchi T, Ogawa H, Yasuda S.

Cardiovasc Diagn Ther. 2016 Aug;6(4):368-81. doi: 10.21037/cdt.2015.12.05. Review.

9.

Stabilization of high-risk plaques.

Takata K, Imaizumi S, Zhang B, Miura S, Saku K.

Cardiovasc Diagn Ther. 2016 Aug;6(4):304-21. doi: 10.21037/cdt.2015.10.03. Review.

10.

Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies.

Andrews J, Puri R, Kataoka Y, Nicholls SJ, Psaltis PJ.

Cardiovasc Diagn Ther. 2016 Aug;6(4):282-303. doi: 10.21037/cdt.2015.10.02. Review.

11.

Effect of n-3 Polyunsaturated Fatty Acids on Regression of Coronary Atherosclerosis in Statin Treated Patients Undergoing Percutaneous Coronary Intervention.

Ahn J, Park SK, Park TS, Kim JH, Yun E, Kim SP, Lee HW, Oh JH, Choi JH, Cha KS, Hong TJ, Lee SY, Lee HC.

Korean Circ J. 2016 Jul;46(4):481-9. doi: 10.4070/kcj.2016.46.4.481.

12.

Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus.

Kennedy MW, Kaplan E, Hermanides RS, Fabris E, Hemradj V, Koopmans PC, Dambrink JH, Marcel Gosselink AT, Van't Hof AW, Ottervanger JP, Roolvink V, Remkes WS, van der Sluis A, Suryapranata H, Kedhi E.

Cardiovasc Diabetol. 2016 Jul 19;15:100. doi: 10.1186/s12933-016-0417-2.

13.

The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.

Feig JE, Feig JL, Dangas GD.

Coron Artery Dis. 2016 Nov;27(7):592-603. doi: 10.1097/MCA.0000000000000408.

PMID:
27414247
14.

Early Effects of Intensive Lipid-Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound.

Lee JH, Shin DH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Yonsei Med J. 2016 Sep;57(5):1087-94. doi: 10.3349/ymj.2016.57.5.1087.

15.

Progression of coronary artery calcification at the crossroads: sign of progression or stabilization of coronary atherosclerosis?

Rodriguez-Granillo GA, Carrascosa P, Bruining N.

Cardiovasc Diagn Ther. 2016 Jun;6(3):250-8. doi: 10.21037/cdt.2016.03.03. Review.

16.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Authors/Task Force Members..

Eur Heart J. 2016 Aug 1;37(29):2315-81. doi: 10.1093/eurheartj/ehw106. No abstract available.

PMID:
27222591
17.

Relationship between left coronary artery bifurcation angle and restenosis after stenting of the proximal left anterior descending artery.

Konishi T, Yamamoto T, Funayama N, Nishihara H, Hotta D.

Coron Artery Dis. 2016 Sep;27(6):449-59. doi: 10.1097/MCA.0000000000000381.

18.

Remarkable regression of coronary atherosclerosis: An interplay of pharmacotherapeutic and lifestyle factors.

Chockalingam P, Vinayagam NS, Chockalingam V, Chockalingam A.

Indian Heart J. 2016 Mar-Apr;68(2):188-9. doi: 10.1016/j.ihj.2015.11.012.

19.

Factors Associated with Lipid Goal Attainment among Patients with Deployed Drug Eluting Stent.

Su MI, Tsai CT, Yeh HI, Chen CY.

Acta Cardiol Sin. 2014 Jul;30(4):325-32.

20.

Assessment of Coronary Plaque Vulnerability with Optical Coherence Tomography.

Uemura S, Soeda T, Sugawara Y, Ueda T, Watanabe M, Saito Y.

Acta Cardiol Sin. 2014 Jan;30(1):1-9. Review.

Supplemental Content

Support Center